Press Releases

Nov 18, 2020 7:00am EST

Greenwich LifeSciences Announces Publication of Positive Phase IIb Clinical Trial Data for GP2, Its Lead Drug Candidate for the Prevention of Recurring Breast Cancer

Nov 12, 2020 9:00am EST

Greenwich LifeSciences, Inc. Announces Partnership with Baylor College of Medicine for its Planned Phase III Clinical Trial

Nov 05, 2020 9:00am EST

Greenwich LifeSciences, Inc. to Participate at Texas Life Sciences Forum Investor Conference

Oct 08, 2020 8:00am EDT

Greenwich LifeSciences, Inc. Announces Acceptance of Two Abstracts at Upcoming Major Breast Cancer Conference

Oct 07, 2020 8:00am EDT

Greenwich LifeSciences, Inc. to Participate at Upcoming Investor and Partnering Conferences

Oct 06, 2020 4:01pm EDT

Greenwich LifeSciences, Inc. Announces Completion of Manufacturing of Drug for its Planned Phase III Clinical Trial

Sep 29, 2020 4:17pm EDT

Greenwich LifeSciences, Inc. Announces Closing of Initial Public Offering

Sep 24, 2020 7:50pm EDT

Greenwich LifeSciences, Inc. Announces Pricing of Initial Public Offering